Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial

Santen, 1990, Endocrine treatment of breast cancer in women, Endocr Rev, 11, 221, 10.1210/edrv-11-2-221

Howell, 1997, Recent advances in endocrine therapy of breast cancer, BMJ, 315, 863, 10.1136/bmj.315.7112.863

1983, Controlled trial of tamoxifen as adjuvant agent in management of early breast cancer, Lancet, 1, 257

1996, Randomized trial of two versus five years of adjuvant tamoxifen for postmenopausal early stage breast cancer, J Natl Cancer Inst, 88, 1543, 10.1093/jnci/88.21.1543

1998, Tamoxifen for early breast cancer: an overview of the randomised trials, Lancet, 351, 1451, 10.1016/S0140-6736(97)11423-4

Love, 1994, Effect of tamoxifen on lumbar spine bone mineral density in postmenopausal women after 5 years, Arch Intern Med, 154, 2585, 10.1001/archinte.1994.00420220081009

2000, Tamoxifen and endometrial cancer, Obstet Gynecol, 95, 1C

Bissett, 1994, Gynaecological monitoring during tamoxifen therapy, Lancet, 344, 1244, 10.1016/S0140-6736(94)90747-1

Fisher, 1989, A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors, N Engl J Med, 320, 479, 10.1056/NEJM198902233200802

Bergman, 2000, Risk and prognosis of endometrial cancer after tamoxifen for breast cancer, Lancet, 356, 881, 10.1016/S0140-6736(00)02677-5

Cutuli, 1994, Adjuvant tamoxifen in breast cancer treatment in postmenopausal women: occurrence of thromboembolic complications, Oncol Rep, 1, 59

Meier, 1998, Tamoxifen and risk of idiopathic venous thromboembolism, Br J Clin Pharm, 45, 608, 10.1046/j.1365-2125.1998.00733.x

Geisler, 1996, Influence of anastrozole (Arimidex), a selective, non-steroidal aromatase inhibitor, on in vivo aromatisation and plasma oestrogen levels in post-menopausal women with breast cancer, Br J Cancer, 74, 1286, 10.1038/bjc.1996.531

Buzdar, 1998, Anastrozole versus megestrol acetate in the treatment of postmenopausal women with advanced breast carcinoma: results of a survival update based on a combined analysis of data from two mature phase III trials, Cancer, 83, 1142, 10.1002/(SICI)1097-0142(19980915)83:6<1142::AID-CNCR13>3.0.CO;2-5

Nabholtz, 2000, Anastrozole is superior to tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: results of a North American multicenter randomized trial, J Clin Oncol, 18, 3758, 10.1200/JCO.2000.18.22.3758

Bonneterre, 2000, Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in 668 postmenopausal women: results of the tamoxifen or Arimidex randomized group efficacy and tolerability study, J Clin Oncol, 18, 3748, 10.1200/JCO.2000.18.22.3748

Bonneterre, 2001, Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinoma: results of two randomized trials designed for combined analysis, Cancer, 92, 2247, 10.1002/1097-0142(20011101)92:9<2247::AID-CNCR1570>3.0.CO;2-Y

1992, Systemic treatment of early breast cancer by hormonal, cytotoxic or immune therapy: 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 women (part I), Lancet, 339, 1

Bernstein, 1999, Tamoxifen therapy for breast cancer and endometrial cancer risk, J Natl Cancer Inst, 91, 1654, 10.1093/jnci/91.19.1654

2001, Pharmacokinetics of anastrozole and tamoxifen alone, and in combination, during adjuvant endocrine therapy for early breast cancer in postmenopausal women: a subgroup of the “Arimidex” and Tamoxifen Alone or in Combination (ATAC) trial, Br J Cancer, 85, 317, 10.1054/bjoc.2001.1925

Cuzick, 1985, Tamoxifen and contralateral breast cancer, Lancet, 2, 282, 10.1016/S0140-6736(85)90338-1

Cuzick, 2000, Future possibilities in the prevention of breast cancer: breast cancer prevention trials, Breast Cancer Res, 2, 258, 10.1186/bcr66

Donnellan, 2001, Aromatase inhibitors and arthralgia, J Clin Oncol, 19, 2767

Andrykowski, 1999, Rheumatoid symptoms following breast cancer treatment: a controlled comparison, J Pain Symptom Manag, 18, 85, 10.1016/S0885-3924(99)00053-6

Loprinzi, 1993, Postchemotherapy Rheum J Clin Oncol, 11, 768, 10.1200/JCO.1993.11.4.768

Wluka, 2000, Menopause, oestrogens and arthritis, Maturitas, 35, 183, 10.1016/S0378-5122(00)00118-3

Van Poznak, 2001, How are bisphosphonates used today in breast cancer clinical practice?, Semin Oncol, 28, 69, 10.1053/sonc.2001.25445

Dewar, 2001, The effect of anastrozole (“Arimidex”) on serum lipids: a randomized comparison of anastrozole (AN) vs. tamoxifen (TAM) in postmenopausal women with advanced breast cancer, Eur J Cancer, 37, 5, 10.1016/S0959-8049(01)80046-0